Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling

被引:96
作者
Soulez, M [1 ]
Parker, MG [1 ]
机构
[1] Imperial Canc Res Fund, Mol Endocrinol Lab, London WC2A 3PX, England
关键词
D O I
10.1677/jme.0.0270259
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oligonucleotide microarrays were used to analyse gene expression profiles in human ZR75-1 breast cancer cells in the presence of 17 beta -oestradiol and oestrogen antagonists. Differential gene expression of a number of genes was confirmed by.. I quantitative RNA analysis. In addition to known oestrogen-responsive genes, an appreciable number of novel targets were identified, including growth factors and components of the cell cycle, adhesion molecules, enzymes, signalling molecules and transcription factors. The most pronounced oestrogen-sensitive gene was that for the cytochrome P450-IIB enzyme, involved in metabolising steroids and xenobiotics, which was increased 100-fold over a 24 h period. It is a direct target gene for oestrogens, because its expression was increased in the presence of cyclohexamide. In contrast, expression of cytochrome P450-IIB was not detected in human MCF7 breast cancer cells. Expressions of the cationic amino acid transporter E16, gap junction protein and insulin-like growth factor binding protein 4 were also markedly increased by oestrogens, but the kinetics of induction varied according to the target gene. With the exception of the cationic amino acid transporter E16 and the insulin-like growth factor binding protein 4, the expression of the majority of the genes was unaffected by antioestrogen treatment. Further analysis of this set of markers will provide alternative approaches to the investigation of the mitogenicity of oestrogens in breast cancer cells.
引用
收藏
页码:259 / 274
页数:16
相关论文
共 32 条
[1]   Gene expression profiling of primary breast carcinomas using arrays of candidate genes [J].
Bertucci, F ;
Houlgatte, R ;
Benziane, A ;
Granjeaud, S ;
Adélaïde, J ;
Tagett, R ;
Loriod, B ;
Jacquemier, J ;
Viens, P ;
Jordan, B ;
Birnbaum, D ;
Nguyen, C .
HUMAN MOLECULAR GENETICS, 2000, 9 (20) :2981-2991
[2]   ACTIVATION OF PS2 GENE-TRANSCRIPTION IS A PRIMARY RESPONSE TO ESTROGEN IN THE HUMAN-BREAST CANCER CELL-LINE MCF-7 [J].
BROWN, AMC ;
JELTSCH, JM ;
ROBERTS, M ;
CHAMBON, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (20) :6344-6348
[3]   SYNTHETIC ANTIESTROGENS MODULATE INDUCTION OF PS2 AND CATHEPSIN-D MESSENGER-RIBONUCLEIC-ACID BY GROWTH-FACTORS AND ADENOSINE-3',5'-MONOPHOSPHATE IN MCF7 CELLS [J].
CHALBOS, D ;
PHILIPS, A ;
GALTIER, F ;
ROCHEFORT, H .
ENDOCRINOLOGY, 1993, 133 (02) :571-576
[4]   Increased autocrine production of insulin-like growth factor II (IGF-II) alters serum sensitivity of MCF-7 human breast cancer cell proliferation [J].
Corcoran, D ;
Perachiotti, A ;
Darbre, PD .
CELL PROLIFERATION, 1996, 29 (09) :479-493
[5]   Antiestrogens - tamoxifen, SERMs and beyond [J].
Dhingra, K .
INVESTIGATIONAL NEW DRUGS, 1999, 17 (03) :285-311
[6]   Characterization of the mouse insulin-like growth factor binding protein 4 gene regulatory region and expression studies [J].
Glantschnig, H ;
Varga, F ;
Luegmayr, E ;
Klaushofer, K .
DNA AND CELL BIOLOGY, 1998, 17 (01) :51-60
[7]   Regulation of cytochrome P450 (CYP) genes by nuclear receptors [J].
Honkakoski, P ;
Negishi, M .
BIOCHEMICAL JOURNAL, 2000, 347 :321-337
[8]  
Howell A, 2000, CANCER-AM CANCER SOC, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO
[9]  
2-6
[10]   Tamoxifen, raloxifene, and the prevention of breast cancer [J].
Jordan, VC ;
Morrow, M .
ENDOCRINE REVIEWS, 1999, 20 (03) :253-278